We are live on
!
Find out more
VP
venBio Partners Portfolio holdings
AUM
$281M
1-Year Est. Return
261.03%
This Fund
S&P 500
This Quarter
Est. Return
-11.71%
1 Year Est. Return
+261.03%
3 Year Est. Return
+648.19%
5 Year Est. Return
+623.84%
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
-$80.6M
(-7.1%)
Cap. Flow
+$72.2M
Cap. Flow
% of AUM
6.86%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
Pharvaris
PHVS
|
+$72.5M |
Top Sells
| 1 |
VRNA
Verona Pharma
VRNA
|
+$308K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
ALX Oncology
ALXO
$264M
| $715M | 67.97% |
9,699,925
| – | – |
|
2
Harmony Biosciences
HRMY
$1.9B
| $116M | 11% |
3,504,624
| – | – |
|
|
AKRO
3
DELISTED
Akero Therapeutics
AKRO
| $70.9M | 6.74% |
2,444,311
| – | – |
|
|
4
Pharvaris
PHVS
$2.43B
| $64.4M | 6.12% |
+2,303,310
| New | +$72.5M |
|
|
CMPI
5
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| $44.6M | 4.24% |
3,673,374
| – | – |
|
|
APLS
6
DELISTED
Apellis Pharmaceuticals
APLS
| $21M | 2% |
490,471
| – | – |
|
|
MTCR
7
DELISTED
Metacrine, Inc. Common Stock
MTCR
| $19M | 1.8% |
3,059,123
| – | – |
|
|
VRNA
8
DELISTED
Verona Pharma
VRNA
| $1.35M | 0.13% |
161,897
-37,178
| -19% | -$308K |
|
Similar funds
OCWP
FFP
BDA
PHC
SA
ACC
NRCM
IP